Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Combine and conquer: manganese synergizing anti-TGF-β/PD-L1 bispecific antibody YM101 to overcome immunotherapy resistance in non-inflamed cancers
Ming Yi, Mengke Niu, Jing Zhang, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 102

Showing 1-25 of 102 citing articles:

Combination strategies with PD-1/PD-L1 blockade: current advances and future directions
Ming Yi, Xiaoli Zheng, Mengke Niu, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 814
Manganese‐Based Tumor Immunotherapy
Ke Zhang, Chao Qi, Kaiyong Cai
Advanced Materials (2022) Vol. 35, Iss. 19
Closed Access | Times Cited: 158
Breast cancer heterogeneity and its implication in personalized precision therapy
Liantao Guo, Deguang Kong, Jianhua Liu, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 137
Tumor organoids: applications in cancer modeling and potentials in precision medicine
Hanxiao Xu, Dechao Jiao, Aiguo Liu, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 133
Research progress on dendritic cell vaccines in cancer immunotherapy
Jifeng Yu, Haowei Sun, Weijie Cao, et al.
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 116
Metabolic profiles of regulatory T cells and their adaptations to the tumor microenvironment: implications for antitumor immunity
Yuheng Yan, Lan Huang, Yiming Liu, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 106
Recent advances in targeted strategies for triple-negative breast cancer
Shuangli Zhu, Yuze Wu, Bin Song, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 103
Combination of oral STING agonist MSA-2 and anti-TGF-β/PD-L1 bispecific antibody YM101: a novel immune cocktail therapy for non-inflamed tumors
Ming Yi, Mengke Niu, Yuze Wu, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 100
Anti-TGF-β/PD-L1 bispecific antibody promotes T cell infiltration and exhibits enhanced antitumor activity in triple-negative breast cancer
Ming Yi, Yuze Wu, Mengke Niu, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 12, pp. e005543-e005543
Open Access | Times Cited: 94
Tumor microenvironment-mediated immune tolerance in development and treatment of gastric cancer
Liu Yuanda, Changfeng Li, Yaoping Lu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 83
Exploiting innate immunity for cancer immunotherapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 78
Exploiting RIG-I-like receptor pathway for cancer immunotherapy
Yangfu Jiang, Hongying Zhang, Jiao Wang, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 69
Multifunctional Mesoporous Polydopamine‐Based Systematic Delivery of STING Agonist for Enhanced Synergistic Photothermal‐Immunotherapy
Wenfeng Zeng, Zimu Li, Qili Huang, et al.
Advanced Functional Materials (2023) Vol. 34, Iss. 1
Closed Access | Times Cited: 59
Immune-checkpoint inhibitor resistance in cancer treatment: Current progress and future directions
Chenyue Zhang, Chenxing Zhang, Haiyong Wang
Cancer Letters (2023) Vol. 562, pp. 216182-216182
Closed Access | Times Cited: 53
The Development of STING Agonists and Emerging Results as a Cancer Immunotherapy
Jacobi Hines, Alec Kacew, Randy F. Sweis
Current Oncology Reports (2023) Vol. 25, Iss. 3, pp. 189-199
Closed Access | Times Cited: 52
Mn-based cGAS-STING activation for tumor therapy
Aiping Huang, Wenhu Zhou
Chinese Journal of Cancer Research (2023) Vol. 35, Iss. 1, pp. 19-43
Open Access | Times Cited: 46
Synergistic efficacy of simultaneous anti-TGF-β/VEGF bispecific antibody and PD-1 blockade in cancer therapy
Mengke Niu, Ming Yi, Yuze Wu, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 45
Targeting cytokine and chemokine signaling pathways for cancer therapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 43
T-cell infiltration and its regulatory mechanisms in cancers: insights at single-cell resolution
Wenhui Yang, Shimao Liu, Mengyun Mao, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 23
Nanomaterial-encapsulated STING agonists for immune modulation in cancer therapy
Xi Chen, Zhijie Xu, Tongfei Li, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 21
Recent advances and challenges of bispecific antibodies in solid tumors
Yuze Wu, Ming Yi, Shuangli Zhu, et al.
Experimental Hematology and Oncology (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 65
Current insight into the regulation of PD-L1 in cancer
Zhuandi Liu, Xibao Yu, Ling Xu, et al.
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 61
TGF-β: A novel predictor and target for anti-PD-1/PD-L1 therapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 53
The Role of the Metabolism of Zinc and Manganese Ions in Human Cancerogenesis
Julian M. Rozenberg, Мargarita Kamynina, Maxim Sorokin, et al.
Biomedicines (2022) Vol. 10, Iss. 5, pp. 1072-1072
Open Access | Times Cited: 43
Hollow Mesoporous Manganese Oxides: Application in Cancer Diagnosis and Therapy
Wenjing Xu, Qing Xin, Shengli Liu, et al.
Small (2022) Vol. 18, Iss. 15
Closed Access | Times Cited: 39
Page 1 - Next Page

Scroll to top